 |
Cladribine |
|---|---|
| Trade Name | Mylinax |
| Orphan Indication | The chronic progressive form of multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1994-04-19 00:00:00 |
| Sponsor | Johnson & Johnson Pharmaceutical R & D, LLC;920 Route 202, PO Box 300;Raritan, New Jersey, 08869 |
